Evidence map›Paper›PMID 37576644›Full record

ArticleACS omega2023

Identification of the

Chonticha Suwattanasophon, Agnes Mistlberger-Reiner, Jon Alberdi-Cedeño, Marc Pignitter, Veronika Somoza, Jürgen König, Thomanai Lamtha, Panatda Wanaragthai, Duangnapa Kiriwan, Kiattawee Choowongkomon

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 4 countries.

Chonticha SuwattanasophonDepartment of Physiological Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria.
Agnes Mistlberger-ReinerDepartment of Physiological Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria.ORCID https://orcid.org/0000-0002-7077-1199
Jon Alberdi-CedeñoDepartment of Physiological Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria.
Marc PignitterDepartment of Physiological Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria.ORCID https://orcid.org/0000-0002-5793-8572
Veronika SomozaDepartment of Physiological Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria.
Jürgen KönigDepartment of Nutritional Sciences, Faculty of Life Sciences, University of Vienna, 1090 Vienna, Austria.
Thomanai LamthaDepartment of Biochemistry, Faculty of Science, Kasetsart University, 10900 Bangkok, Thailand.
Panatda WanaragthaiInterdisciplinary Program of Genetic Engineering and Bioinformatics, Graduate School, Kasetsart University, 10900 Bangkok, Thailand.
Duangnapa KiriwanInterdisciplinary Program of Genetic Engineering and Bioinformatics, Graduate School, Kasetsart University, 10900 Bangkok, Thailand.
Kiattawee ChoowongkomonDepartment of Biochemistry, Faculty of Science, Kasetsart University, 10900 Bangkok, Thailand.ORCID https://orcid.org/0000-0002-2421-7859
University of Vienna · ATKasetsart University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhibitors of the tyrosine kinase (TK) activity of the epidermal growth factor receptor (EGFR) are routinely used in cancer therapy. However, there is a need to discover a new TK inhibitor. This study evaluated extracts from

Identifiers

PMID37576644
PMCPMC10413460
OpenAlexW4385341781

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.